Does Colgate-Palmolive Company (CL) Present Much Upside ?

Colgate-Palmolive Company (NYSE:CL) seems to be forming a pattern of major movements, providing only some crumbs of outlook for market participants trying to figure out its next move. Now trading with a market value of 61.84B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. Everyone seems to have their own opinion of this stock. But what do the numbers really say? We think it’s a great time to take a fresh look.

Colgate-Palmolive Company (NYSE:CL) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For CL, the company currently has 1.54 billion of cash on the books, which is offset by 11 million in current liabilities. The trend over time is important to note. In this case, the company’s debt has been falling. The company also has 12.68 billion in total assets, balanced by 12.43 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Colgate-Palmolive Company (CL) saw 588 million in free cash flow last quarter, representing a quarterly net change in cash of 155 million. Perhaps most importantly where cash movements are concerned, the company saw about 759 million in net operating cash flow.

Colgate-Palmolive Company (NYSE:CL) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 3.89 billion in total revenues. That represents a quarterly year/year change in revenues of 0.05 in sequential terms, the CL saw sales decline by -0.02.

But what about the bottom line? After all, that’s what really matters in the end. Colgate-Palmolive Company (CL) is intriguing when broken down to its core data. The cost of selling goods last quarter was 1.54 billion, yielding a gross basic income of 2.35 billion. For shareholders, given the total diluted outstanding shares of 883.3 million, this means overall earnings per share of 0.37. Note, this compares with a consensus analyst forecast of 0.74 in earnings per share for its next fiscal quarterly report.

Is Colgate-Palmolive Company (NYSE:CL) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 3.44 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 20.27. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Colgate-Palmolive Company.

Previous ArticleNext Article

Related Post

Idera Pharmaceuticals, Inc. (IDRA) Is Flashing No ... Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) gained 4.48% in yesterday’s session, going up from its prior closing price of $2.23 to $2.33, and has now re...
Did Brocade Communications Systems, Inc. (BRCD) Tr... Brocade Communications Systems, Inc. (NASDAQ:BRCD) gained 0.74% in yesterday’s session, going up from its prior closing price of $12.16 to $12.25, and...
Coherus Biosciences, Inc. (CHRS): Are There Still ... Coherus Biosciences, Inc. (NASDAQ:CHRS) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value o...
Antero Resources Corporation (AR): How Do the Book... Antero Resources Corporation (NYSE:AR) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decisio...
Taking a Look at the Operational Data for Marathon... Marathon Petroleum Corporation (NYSE:MPC) is in the highlights and many would want to know whether now might be a good time for it to present much ups...